LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

LCMS webinars focusing on LC/TOF - page 21

Advances in Proteomics & Metabolomics 2023 - Day 2

Advances in Proteomics & Metabolomics 2023 - Day 2

Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.
RECORD
|
Already taken place Th, 12.10.2023
Technology Networks
tag
share
more
Advances in Proteomics & Metabolomics 2023 - Day 2
Advances in Proteomics & Metabolomics 2023 - Day1

Advances in Proteomics & Metabolomics 2023 - Day1

Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.
RECORD
|
Already taken place We, 11.10.2023
Technology Networks
tag
share
more
Advances in Proteomics & Metabolomics 2023 - Day1
The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays

The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays

The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays.
RECORD
|
Already taken place Tu, 10.10.2023
Agilent Technologies
tag
share
more
The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays
What is Mass Spectrometry Imaging?

What is Mass Spectrometry Imaging?

We will examine the types of MS imaging techniques on the market and the platforms on which they can be run.
RECORD
|
Already taken place Tu, 10.10.2023
Waters Corporation
tag
share
more
What is Mass Spectrometry Imaging?
Get the Perfect Answer for Synthetic Peptides & Oligonucleotides

Get the Perfect Answer for Synthetic Peptides & Oligonucleotides

Emerging therapies like Synthetic Peptides & Oligonucleotides are catching the attention due to its capabilities to improve their properties.
RECORD
|
Already taken place Th, 5.10.2023
Agilent Technologies
tag
share
more
Get the Perfect Answer for Synthetic Peptides & Oligonucleotides
Powerful Multimodal Clinical Imaging System with LA-ICP-MS and MALDI-MS Microscopy

Powerful Multimodal Clinical Imaging System with LA-ICP-MS and MALDI-MS Microscopy

The Laser-ablation ICP-MS, which acquires information on the element distribution, and the award-winning iMScope QT MALDI-MS Microscope, which provide information on the compound distribution.
RECORD
|
Already taken place Th, 5.10.2023
Shimadzu Corporation
tag
share
more
Powerful Multimodal Clinical Imaging System with LA-ICP-MS and MALDI-MS Microscopy
Accelerated Imaging Clarity

Accelerated Imaging Clarity

In our applications demo lab we will show the simplicity of changing between MALDI and DESI XS modes, both available on the MRT instrument.
RECORD
|
Already taken place We, 4.10.2023
Waters Corporation
tag
share
more
Accelerated Imaging Clarity
Towards more Comprehensive Characterization of PFAS Exposure using Ion Mobility and High-Resolution Mass Spectrometry

Towards more Comprehensive Characterization of PFAS Exposure using Ion Mobility and High-Resolution Mass Spectrometry

Towards more Comprehensive Characterization of PFAS Exposure using Ion Mobility and High-Resolution Mass Spectrometry.
RECORD
|
Already taken place Tu, 3.10.2023
Agilent Technologies
tag
share
more
Towards more Comprehensive Characterization of PFAS Exposure using Ion Mobility and High-Resolution Mass Spectrometry
Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment

Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment

Uses of the Xevo G3 QTof mass spectrometer in a case study of biosimilar mAb characterization at intact, subunit, and peptide level.
RECORD
|
Already taken place Th, 28.9.2023
Waters Corporation
tag
share
more
Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment
Solving challenges in the determination of pyrrolizidine alkaloids via LC-MS/MS and LC-IM-HRMS

Solving challenges in the determination of pyrrolizidine alkaloids via LC-MS/MS and LC-IM-HRMS

How our latest solutions meet industry demands, such as high throughput, enhanced sensitivity requirements, increased accuracy, and compliance.
RECORD
|
Already taken place Th, 28.9.2023
Waters Corporation
tag
share
more
Solving challenges in the determination of pyrrolizidine alkaloids via LC-MS/MS and LC-IM-HRMS
 

Related content

Dissecting Heterogeneous Populations of Protein-Complex Samples Using Direct Mass Technology

Dissecting Heterogeneous Populations of Protein-Complex Samples Using Direct Mass Technology

Mo, 9.2.2026
LabRulez
Webinars LabRulezLCMS Week 07/2026

Webinars LabRulezLCMS Week 07/2026

Mo, 9.2.2026
LabRulez
Affinity, Gel Filtration, Size Exclusion Chromatography: Repurposing Kinase Inhibitors for Malaria

Affinity, Gel Filtration, Size Exclusion Chromatography: Repurposing Kinase Inhibitors for Malaria

Fr, 6.2.2026
Organomation
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike